Cargando…

Correlation between Macular Neovascularization (MNV) Type and Druse Type in Neovascular Age-Related Macular Degeneration (AMD) Based on the CONAN Classification

To investigate associations and predictive factors between macular neovascularization (MNV) lesion variants and drusen types in patients with treatment-naïve neovascular age-related macular degeneration (AMD). Methods: Multimodal imaging was retrospectively reviewed for druse type (soft drusen, subr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muth, Daniel Rudolf, Toro, Mario Damiano, Bajka, Anahita, Jonak, Kamil, Rieder, Roman, Kohler, Myrtha Magdalena, Gunzinger, Jeanne Martine, Souied, Eric H., Engelbert, Michael, Freund, K. Bailey, Zweifel, Sandrine Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598373/ https://www.ncbi.nlm.nih.gov/pubmed/36289632 http://dx.doi.org/10.3390/biomedicines10102370

Ejemplares similares

The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD
por: Faatz, Henrik, et al.
Publicado: (2022)

Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
por: Tilleul, Julien, et al.
Publicado: (2014)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown
por: Arruabarrena, Carolina, et al.
Publicado: (2021)

Progression from Type 2 Macular Neovascularization to Fibrovascular Pigment Epithelial Detachment
por: LE, Hoang Mai, et al.
Publicado: (2021)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021)

The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD
por: Viggiano, Pasquale, et al.
Publicado: (2023)

Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study
por: Ward, Elizabeth, et al.
Publicado: (2020)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
por: Chandran, Kiran, et al.
Publicado: (2023)

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
por: Sarkar, Aira, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

Macular neovascularization in eyes with pachydrusen
por: Teo, Kelvin Yi Chong, et al.
Publicado: (2021)

InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years
por: Cozzupoli, Grazia M., et al.
Publicado: (2022)

Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Undetectable Macular Neovascularization on OCT Angiography in Age Related Macular Degeneration: Comparison between Different Devices
por: Filali Ansary, Meryem, et al.
Publicado: (2022)

Choroidal and Retinal Imaging Biomarkers in Different Types of Macular Neovascularization
por: Toto, Lisa, et al.
Publicado: (2023)

Morphological and Functional Relationship Between OCTA and FA/ICGA Quantitative Features in AMD-Related Macular Neovascularization
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Swept-Source OCT Angiographic Characteristics of Treatment-Naïve Nonexudative Macular Neovascularization in AMD Prior to Exudation
por: Shen, Mengxi, et al.
Publicado: (2021)

The RAP study, report 3: Discoloration of the macular region in patients with macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Choroidal Changes After Anti-VEGF Therapy in AMD Eyes With Different Types of Macular Neovascularization Using Swept-Source OCT Angiography
por: Shen, Mengxi, et al.
Publicado: (2023)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2022)

Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
por: Matsumoto, Hidetaka, et al.
Publicado: (2023)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Imaging Biomarkers of 1-Year Activity in Type 1 Macular Neovascularization
por: Costanzo, Eliana, et al.
Publicado: (2021)

Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration
por: Razavi, Sam, et al.
Publicado: (2021)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Early OCT Angiography Changes of Macular Neovascularization in Patients with Exudative AMD Treated with Brolucizumab in a Real-World Setting
por: Rübsam, Anne, et al.
Publicado: (2022)

Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD)
por: Douglas, Vivian Paraskevi, et al.
Publicado: (2022)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
por: Ferrante, Nicola, et al.
Publicado: (2022)

Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
por: Cabral, Diogo, et al.
Publicado: (2023)

Clinical Pathological Features and Current Animal Models of Type 3 Macular Neovascularization
por: Qiang, Wei, et al.
Publicado: (2021)

Blood flow pattern in eye before development of type 3 macular neovascularization
por: Yamaguchi, Saya, et al.
Publicado: (2023)

Genetic association study of mitochondrial polymorphisms in neovascular age-related macular degeneration
por: Tilleul, Julien, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sf7rnjrjss9c9afda2htajl254